Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial.

Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial.

BACKGROUND: Japanese encephalitis virus (JEV), although confined to Asia, causes about 35000-50000 cases and 10000 deaths every year, and is the most important cause of encephalitis worldwide. There is no known antiviral treatment for any flavivirus. Results from in-vitro studies and work in animal...

Descrición completa

Detalles Bibliográficos
Main Authors:	Solomon, T, Dung, N, Wills, B, Kneen, R, Gainsborough, M, Diet, T, Thuy, T, Loan, H, Khanh, VC, Vaughn, D, White, N, Farrar, J
Formato:	Journal article
Idioma:	English
Publicado:	2003

Títulos similares

Interferon alpha in the pathogenesis and treatment Japanese encephalitis
por: Solomon, T, et al.
Publicado: (2004)

Poliomyelitis-like illness due to Japanese encephalitis virus.
por: Solomon, T, et al.
Publicado: (1998)

Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis.
por: Solomon, T, et al.
Publicado: (2002)

Proinflammatory cytokines and chemokines in humans with Japanese encephalitis.
por: Winter, P, et al.
Publicado: (2004)

An evaluation of the usefulness of neuroimaging for the diagnosis of Japanese encephalitis.
por: Dung, N, et al.
Publicado: (2009)

Polymorphisms of the gene coding for copper/zinc superoxide dismutase (SOD1) in patients with Japanese encephalitis.
por: Thuong, N, et al.
Publicado: (2006)

Polymorphisms of the gene coding for copper/zinc superoxide dismutase (SOD1) in patients with Japanese encephalitis
por: Thuong, N, et al.
Publicado: (2006)

Rapid diagnosis of Japanese encephalitis by using an immunoglobulin M dot enzyme immunoassay.
por: Solomon, T, et al.
Publicado: (1998)

Failure of interferon alfa and tribavirin in rabies encephalitis.
por: Warrell, M, et al.
Publicado: (1989)

FAILURE OF INTERFERON ALFA AND TRIBAVIRIN IN RABIES ENCEPHALITIS
por: Warrell, M, et al.
Publicado: (1989)

A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in Nepal.
por: Ajit Rayamajhi, et al.
Publicado: (2015-01-01)

Correction: A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal.
por: Ajit Rayamajhi, et al.
Publicado: (2015-01-01)

Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens.
por: Dung, N, et al.
Publicado: (1999)

Fluid resuscitation for dengue shock syndrome - The evidence from formal randomised and blinded intervention trials in Vietnam
por: Wills, B, et al.
Publicado: (2005)

A cohort study to assess the new WHO Japanese encephalitis surveillance standards
por: Tom Solomon, et al.
Publicado: (2008-03-01)

Comparison of peginterferon alfa-2a and alfa-2b for treatment of patients with chronic hepatitis C:a retrospective study using the Japanese Interferon Database
por: Sato I, et al.
Publicado: (2014-12-01)

"Can't you use another vaccine?" Postrabies vaccination encephalitis.
por: Chau, N, et al.
Publicado: (1999)

Systemic interferon alfa in multiple sclerosis.
por: Weinshenker, BG, et al.
Publicado: (1989)

Mx Is Not Responsible for the Antiviral Activity of Interferon-α against Japanese Encephalitis Virus
por: Jing Zhou, et al.
Publicado: (2017-01-01)

Thyrotoxicosis with pegylated interferon alfa-2b.
por: Lowndes, SA, et al.
Publicado: (2010)

Lovastatin for the treatment of adult patients with dengue: A randomized, double-blind, placebo-controlled trial.
por: Whitehorn, J, et al.
Publicado: (2016)

A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model.
por: German, A, et al.
Publicado: (2006)

Interferón alfa y diabetes mellitus tipo 1
por: Alieski Cruz Ramírez, et al.

Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour.
por: Ngo, N, et al.
Publicado: (2001)

Japanese Encephalitis
por: Asri Hendrawati
Publicado: (2019-04-01)

Cell-surface neuronal antibodies in patients with Japanese encephalitis virus
por: Nibber, A, et al.
Publicado: (2014)

Interferon alfa-2b in the management of recurrent conjunctival papillomatosis
por: Manpreet Singh, et al.
Publicado: (2016-01-01)

Autoanticuerpos en pacientes hematológicos tratados con interferón alfa
por: Antonio A Bencomo Hernández, et al.

Congenital Zika Syndrome Is Associated With Interferon Alfa Receptor 1
por: Tamiris Azamor, et al.
Publicado: (2021-11-01)

Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2
por: Jingyuan Liu, et al.
Publicado: (2021-08-01)

Neurological manifestations of dengue infection.
por: Solomon, T, et al.
Publicado: (2000)

Japanese encephalitis in children
por: Nurhayati Masloman, et al.
Publicado: (2016-10-01)

Cysticercosis and Japanese Encephalitis
por: Beuy Joob, et al.
Publicado: (2016-12-01)

Efficacy of pegylated interferon alfa-2b «Algeron» in the treatment of chronic hepatitis C
por: M. V. Mayevskaya, et al.
Publicado: (2013-03-01)

Encephalitis in children.
por: Thompson, C, et al.
Publicado: (2012)

Encephalitis in children
por: Thompson, C, et al.
Publicado: (2012)

Immunohistochemistry on skin biopsies from Vietnamese patients with dengue shock syndrome
por: Wills, B, et al.
Publicado: (2007)

Crystal Structure of the Japanese Encephalitis Virus Capsid Protein
por: Thanalai Poonsiri, et al.
Publicado: (2019-07-01)

Investigation of dengue and Japanese encephalitis virus transmission in Hanam, Viet Nam
por: Fox, A, et al.
Publicado: (2014)

Investigation of dengue and Japanese encephalitis virus transmission in Hanam, Viet Nam.
por: Fox, A, et al.
Publicado: (2014)